Related Experiment Video
Updated: Jun 4, 2025

07:44
In vivo Structural Assessments of Ocular Disease in Rodent Models using Optical Coherence Tomography
Published on: July 24, 2020
2.8K
Advancements in Ocular Modelling and Simulations: Key Considerations and Case Studies.
Mohammed Shareef Khan1, Aditya Murthy2, Tausif Ahmed3
1Biopharmaceutics - Biopharmaceutics and Bioequivalence, Global Clinical Management, Dr. Reddy's Laboratories Ltd, Hyderabad, India. mohammedshareefkhan@drreddys.com.
AAPS Pharmscitech
|December 17, 2024
Summary
Ocular biopharmaceutics and drug delivery are optimized using ocular compartmental modeling and simulation. This approach enhances understanding of eye physiology and disease for targeted therapies.
Area of Science:
- Ophthalmology
- Pharmaceutics
- Biomedical Engineering
Background:
- The eye's complex structure necessitates specialized drug delivery systems.
- Ocular diseases require precise therapeutic interventions.
- Current ocular drug delivery methods face significant challenges.
Purpose of the Study:
- To review ocular biopharmaceutics, focusing on modeling and simulation.
- To explore drug delivery formulations and administration routes for ocular therapies.
- To highlight the role of ocular compartmental modeling in understanding eye diseases.
Main Methods:
- Comprehensive literature review of ocular biopharmaceutics.
- Analysis of ocular compartmental modeling and simulation techniques.
- Discussion of various ocular drug delivery formulations and administration routes.
Main Results:
- Ocular compartmental modeling provides critical insights into drug distribution and release kinetics.
- Understanding eye physiology is key to optimizing drug delivery.
- Various formulations offer distinct advantages and limitations for ocular drug delivery.
Conclusions:
- Ocular compartmental modeling and simulation are essential tools for advancing ocular drug delivery.
- Targeted drug delivery strategies can be significantly improved through modeling.
- This review serves as a reference for optimizing ocular therapies.

